Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes

Overview

Journal Eur Urol Open Sci

Date 2022 Feb 24

PMID 35199040

Authors

Giorgio Gandaglia

Antony Pellegrino

Francesco Montorsi

Alberto Briganti

Affiliations

Soon will be listed here.

Citing Articles

Comparing Two Targeted Biopsy Schemes for Detecting Clinically Significant Prostate Cancer in Magnetic Resonance Index Lesions: Two- to Four-Core versus Saturated Transperineal Targeted Biopsy.

Morote J, Paesano N, Picola N, Miro B, Abascal J, Servian P Cancers (Basel). 2024; 16(13).

PMID: 39001369 PMC: 11240532. DOI: 10.3390/cancers16132306.

The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Magnetic Resonance Imaging Undergoing Robot-assisted Radical Prostatectomy for Prostate Cancer.

van den Kroonenberg D, Stoter J, Jager A, Veerman H, Hagens M, Schoots I Eur Urol Open Sci. 2024; 63:13-18.

PMID: 38558763 PMC: 10981034. DOI: 10.1016/j.euros.2024.03.006.

References

Drost F, Osses D, Nieboer D, Steyerberg E, Bangma C, Roobol M . Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019; 4:CD012663. PMC: 6483565. DOI: 10.1002/14651858.CD012663.pub2. View

Rouviere O, Puech P, Renard-Penna R, Claudon M, Roy C, Mege-Lechevallier F . Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2018; 20(1):100-109. DOI: 10.1016/S1470-2045(18)30569-2. View

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Roumiguie M . The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical.... Eur Urol. 2019; 77(6):733-741. DOI: 10.1016/j.eururo.2019.09.005. View

Roobol M, Verbeek J, van der Kwast T, Kummerlin I, Kweldam C, van Leenders G . Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth. Eur Urol. 2017; 72(1):45-51. DOI: 10.1016/j.eururo.2017.01.033. View

Delloglio P, Stabile A, Soligo M, Brembilla G, Esposito A, Gandaglia G . There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies. Eur Urol Oncol. 2019; 3(1):112-118. DOI: 10.1016/j.euo.2019.03.002. View

Gandaglia G, Martini A, Ploussard G, Fossati N, Stabile A, De Visschere P . External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection. Eur Urol. 2020; 78(2):138-142. DOI: 10.1016/j.eururo.2020.03.023. View

Gandaglia G, Ploussard G, Valerio M, Marra G, Moschini M, Martini A . Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted.... Eur Urol Oncol. 2020; 3(6):739-747. DOI: 10.1016/j.euo.2020.07.008. View

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N . A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Eur Urol. 2018; 75(3):506-514. DOI: 10.1016/j.eururo.2018.10.012. View

Stabile A, Delloglio P, De Cobelli F, Esposito A, Gandaglia G, Fossati N . Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer. Eur Urol Oncol. 2019; 1(1):29-36. DOI: 10.1016/j.euo.2018.01.002. View

10.

van der Leest M, Cornel E, Israel B, Hendriks R, Padhani A, Hoogenboom M . Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large.... Eur Urol. 2018; 75(4):570-578. DOI: 10.1016/j.eururo.2018.11.023. View

11.

Chesnut G, Vertosick E, Benfante N, Sjoberg D, Fainberg J, Lee T . Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. 2019; 77(4):501-507. PMC: 7096768. DOI: 10.1016/j.eururo.2019.12.009. View

12.

Johnson D, Raman S, Mirak S, Kwan L, Bajgiran A, Hsu W . Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2018; 75(5):712-720. DOI: 10.1016/j.eururo.2018.11.031. View

13.

Kasivisvanathan V, Rannikko A, Borghi M, Panebianco V, Mynderse L, Vaarala M . MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018; 378(19):1767-1777. PMC: 9084630. DOI: 10.1056/NEJMoa1801993. View

14.

Mottet N, van den Bergh R, Briers E, Van den Broeck T, Cumberbatch M, De Santis M . EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2020; 79(2):243-262. DOI: 10.1016/j.eururo.2020.09.042. View